Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_assertion type Assertion NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_head.
- NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_provenance.
- NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_assertion evidence source_evidence_literature NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_provenance.
- NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_assertion SIO_000772 24014145 NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_provenance.
- NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_assertion wasDerivedFrom befree-20150227 NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_provenance.
- NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_assertion wasGeneratedBy ECO_0000203 NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_provenance.